FAIM
SNY icon

Financial Advocates Investment Management’s Sanofi SNY Stock Holding History

Financial Advocates Investment Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,536
Closed -$362K – 756
2025
Q1 		$362K Buy
6,536
+827
+14% +$44.8K 0.03% 511
2024
Q4 		$275K Sell
5,709
-618
-10% -$31.4K 0.02% 618
2024
Q3 		$365K Buy
6,327
+206
+3% +$11.1K 0.02% 551
2024
Q2 		$297K Sell
6,121
-1,080
-15% -$52.1K 0.02% 576
2024
Q1 		$350K Buy
7,201
+1,870
+35% +$91.3K 0.02% 540
2023
Q4 		$265K Sell
5,331
-44
-0.8% -$2.15K 0.02% 598
2023
Q3 		$288K Buy
5,375
+373
+7% +$19.9K 0.02% 534
2023
Q2 		$270K Buy
+5,002
New +$269K 0.02% 550
2022
Q1 		– Sell
-79,832
Closed -$3.15M – 806
2021
Q4 		$3.15M Buy
+79,832
New +$3.95M 0.2% 124

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Financial Advocates Investment Management's SNY Position: Q2 2025 in Review

Financial Advocates Investment Management sold out of Sanofi (SNY) in Q2 2025, closing a stake of 6,536 shares — an estimated $362K sold.

Financial Advocates Investment Management first reported a position in SNY in Q4 2021 and held it in 9 quarters. The position peaked at $3.15M in Q4 2021. 731 funds tracked by Wall St. Rank hold SNY as of Q2 2025.

  • Financial Advocates Investment Management reported no remaining Sanofi position as of Q2 2025 after selling out during the quarter.
  • Financial Advocates Investment Management sold 6,536 Sanofi shares in Q2 2025, an estimated $362K.
  • Financial Advocates Investment Management first reported a position in Sanofi in Q4 2021 and held it in 9 quarters.
  • Financial Advocates Investment Management's Sanofi position peaked at $3.15M in Q4 2021.
  • 731 funds tracked by Wall St. Rank held Sanofi as of Q2 2025.

Based on Financial Advocates Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.